The Post-Stroke Checklist: longitudinal use in routine clinical practice during first year after stroke.


Journal

BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 18 01 2024
accepted: 07 10 2024
medline: 29 10 2024
pubmed: 29 10 2024
entrez: 29 10 2024
Statut: epublish

Résumé

Few studies describe the use of the Post-Stroke Checklist (PSC) as a tool for longitudinal stroke follow-up in clinical practice. We mapped the prevalence of stroke-related health problems and targeted interventions at 3 and 12 months post-stroke by using the PSC. Patients with acute stroke discharged home in 2018-2019 at Skåne University Hospital, Sweden, were invited to participate in a comprehensive nurse-led follow-up based on a 14-item PSC 3 and 12 months post-stroke. We measured time consumption, screened for stroke-related health problems, compared the findings, and recorded targeted healthcare interventions. Problems at 12 months were grouped into new, persistent, or none compared to the 3-month evaluation. Of 200 consecutively included patients, 146 (77%) completed both the 3- and 12-month follow-ups. At 12-month follow-up, 36% of patients reported no stroke-related health problems, 24% reported persistent problems, and 40% reported new problems since the 3-month evaluation. New problems at 12 months were most common within the domains: secondary prevention (23%) and life after stroke (10%). Stroke recurrence rate was 7.5%, 43% had high blood pressure, and few smokers had quit smoking. At 12 months, 53% received at least one new healthcare intervention, compared to 84% at 3 months. Stroke-related health problems decreased beyond 3 months but were still present in two-thirds of patients at 1 year. This emphasizes the relevance of continuous structured follow-up using the PCS. However, the follow-up alone was insufficient to adequately achieve treatment targets for secondary prevention, which require intensified focus. ClinicalTrials.gov ID NCT04295226, (04/03/2020).

Sections du résumé

BACKGROUND BACKGROUND
Few studies describe the use of the Post-Stroke Checklist (PSC) as a tool for longitudinal stroke follow-up in clinical practice. We mapped the prevalence of stroke-related health problems and targeted interventions at 3 and 12 months post-stroke by using the PSC.
METHODS METHODS
Patients with acute stroke discharged home in 2018-2019 at Skåne University Hospital, Sweden, were invited to participate in a comprehensive nurse-led follow-up based on a 14-item PSC 3 and 12 months post-stroke. We measured time consumption, screened for stroke-related health problems, compared the findings, and recorded targeted healthcare interventions. Problems at 12 months were grouped into new, persistent, or none compared to the 3-month evaluation.
RESULTS RESULTS
Of 200 consecutively included patients, 146 (77%) completed both the 3- and 12-month follow-ups. At 12-month follow-up, 36% of patients reported no stroke-related health problems, 24% reported persistent problems, and 40% reported new problems since the 3-month evaluation. New problems at 12 months were most common within the domains: secondary prevention (23%) and life after stroke (10%). Stroke recurrence rate was 7.5%, 43% had high blood pressure, and few smokers had quit smoking. At 12 months, 53% received at least one new healthcare intervention, compared to 84% at 3 months.
CONCLUSIONS CONCLUSIONS
Stroke-related health problems decreased beyond 3 months but were still present in two-thirds of patients at 1 year. This emphasizes the relevance of continuous structured follow-up using the PCS. However, the follow-up alone was insufficient to adequately achieve treatment targets for secondary prevention, which require intensified focus.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov ID NCT04295226, (04/03/2020).

Identifiants

pubmed: 39468444
doi: 10.1186/s12872-024-04239-6
pii: 10.1186/s12872-024-04239-6
doi:

Banques de données

ClinicalTrials.gov
['NCT04295226']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

601

Informations de copyright

© 2024. The Author(s).

Références

Rajsic S, Gothe H, Borba HH, et al. Economic burden of stroke: a systematic review on post-stroke care. Eur J Health Econ. 2019;20:107–34. https://doi.org/10.1007/s10198-018-0984-0 . 2018/06/18.
doi: 10.1007/s10198-018-0984-0 pubmed: 29909569
Wafa HA, Wolfe CDA, Emmett E, et al. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51:2418–27. 2020/07/11.
doi: 10.1161/STROKEAHA.120.029606 pubmed: 32646325 pmcid: 7382540
Global regional, national burden of neurological disorders. 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18:459–80. https://doi.org/10.1016/s1474-4422(18)30499-x . 2019/03/19.
doi: 10.1016/s1474-4422(18)30499-x
Norrving B, Barrick J, Davalos A, et al. Action Plan for Stroke in Europe 2018–2030. Eur Stroke J. 2018;3:309–36. https://doi.org/10.1177/2396987318808719 . 2019/06/27.
doi: 10.1177/2396987318808719 pubmed: 31236480 pmcid: 6571507
Europe SAP. accessed June 13,. Life after Stroke, https://actionplan.eso-stroke.org/domains/life-after-stroke (2023).
Socialstyrelsen. accessed August, 10,. Nationella riktlinjer för vård vid stroke, https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/nationella-riktlinjer/2020-1-6545.pdf (2022).
Programme SSNA. National Results - Clinical https://www.strokeaudit.org/Results2/Clinical-audit/National-Results.aspx (accessed March, 13, 2023).
Riksstroke. Stroke och TIA. Riksstrokes årsrapport 2022., https://www.riksstroke.org/wp-content/uploads/2023/12/Riksstroke_Arsrapport_2022.pdf (accessed 2023-12-01).
Boehme C, Toell T, Lang W, et al. Longer term patient management following stroke: a systematic review. Int J Stroke. 2021;17474930211016963. October 2021/05/06.
Willeit P, Toell T, Boehme C, et al. STROKE-CARD care to prevent cardiovascular events and improve quality of life after acute ischaemic stroke or TIA: a randomised clinical trial. EClinicalMedicine. 2020;25:100476. https://doi.org/10.1016/j.eclinm.2020.100476 .
doi: 10.1016/j.eclinm.2020.100476 pubmed: 32954239 pmcid: 7486330
Ward AB, Chen C, Norrving B, et al. Evaluation of the Post Stroke Checklist: a pilot study in the United Kingdom and Singapore. Int J Stroke. 2014;9(Suppl A):76–84. https://doi.org/10.1111/ijs.12291 .
doi: 10.1111/ijs.12291 pubmed: 25088427
Philp I, Brainin M, Walker MF, et al. Development of a poststroke checklist to standardize follow-up care for stroke survivors. J Stroke Cerebrovasc Dis. 2013;22:e173–180. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.10.016 .
doi: 10.1016/j.jstrokecerebrovasdis.2012.10.016 pubmed: 23265778
Olver J, Yang S, Fedele B, et al. Post Stroke Outcome: global insight into Persisting Sequelae using the Post Stroke Checklist. J Stroke Cerebrovasc Dis. 2021;30:105612. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105612 .
doi: 10.1016/j.jstrokecerebrovasdis.2021.105612 pubmed: 33493876
Iosa M, Lupo A, Morone G, et al. Post Soft Care: Italian implementation of a post-stroke checklist software for primary care and identification of unmet needs in community-dwelling patients. Neurol Sci. 2018;39:135–9. 2017/11/01.
doi: 10.1007/s10072-017-3140-1 pubmed: 29086123
Im HW, Kim WS, Kim S, et al. Prevalence of worsening problems using Post-stroke Checklist and associations with Quality of Life in patients with stroke. J Stroke Cerebrovasc Dis. 2020;29:105406. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105406 .
doi: 10.1016/j.jstrokecerebrovasdis.2020.105406 pubmed: 33254377
Crow J, Savage M, Gardner L, et al. What follow-up interventions, programmes and pathways exist for minor stroke survivors after discharge from the acute setting? A scoping review. BMJ Open. 2023;13:e070323. https://doi.org/10.1136/bmjopen-2022-070323 .
doi: 10.1136/bmjopen-2022-070323 pubmed: 37311634 pmcid: 10277077
Ullberg T, Mansson K, Berhin I, et al. Comprehensive and structured 3-month Stroke follow-up using the Post-stroke Checklist (the Struct-FU study): a feasibility and explorative study. J Stroke Cerebrovasc Dis. 2021;30:105482. 2020/12/01.
doi: 10.1016/j.jstrokecerebrovasdis.2020.105482 pubmed: 33253985
Skåne R. Post stroke checklist, https://vardgivare.skane.se/siteassets/1.-vardriktlinjer/regionala-riktlinjer---fillistning/checklista_2018-final.pdf (2018,).
Kjörk EK, Carlsson G, Sunnerhagen KS, et al. Experiences using the poststroke checklist in Sweden with a focus on feasibility and relevance: a mixed-method design. BMJ Open. 2019;9:e028218. https://doi.org/10.1136/bmjopen-2018-028218 .
doi: 10.1136/bmjopen-2018-028218 pubmed: 31072862 pmcid: 6528008
Riksstroke, editor. The Swedish Stroke Register (Riksstroke), https://www.riksstroke.org/eng/
Riksstroke. TIA och stroke. Riksstrokes årsrapport 2018., https://www.riksstroke.org/wp-content/uploads/2019/09/Riksstroke_A%CC%8Arsrapport-2018_slutversionWEB.pdf (2019, accessed 2024-08-28).
Kapoor A, Lanctôt KL, Bayley M, et al. Good outcome isn’t good enough: cognitive impairment, depressive symptoms, and Social Restrictions in physically recovered stroke patients. Stroke. 2017;48:1688–90. https://doi.org/10.1161/strokeaha.117.016728 .
doi: 10.1161/strokeaha.117.016728 pubmed: 28438907
Esenwa C, Gutierrez J. Secondary stroke prevention: challenges and solutions. Vasc Health Risk Manag 2015; 11: 437–450. 20150807. https://doi.org/10.2147/vhrm.S63791
Heuschmann PU, Kircher J, Nowe T, et al. Control of main risk factors after ischaemic stroke across Europe: data from the stroke-specific module of the EUROASPIRE III survey. Eur J Prev Cardiol. 2015;22(20140819):1354–62. https://doi.org/10.1177/2047487314546825 .
doi: 10.1177/2047487314546825 pubmed: 25139770
Brewer L, Mellon L, Hall P, et al. Secondary prevention after ischaemic stroke: the ASPIRE-S study. BMC Neurol. 2015;15:216. https://doi.org/10.1186/s12883-015-0466-2 .
doi: 10.1186/s12883-015-0466-2 pubmed: 26492943 pmcid: 4619229
Hotter B, Padberg I, Liebenau A, et al. Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-stroke Checklist - The Managing Aftercare for Stroke (MAS-I) study. Eur Stroke J. 2018;3(20180419):237–45. https://doi.org/10.1177/2396987318771174 .
doi: 10.1177/2396987318771174 pubmed: 31008354 pmcid: 6453198
Hughes LD, McMurdo ME, Guthrie B. Guidelines for people not for diseases: the challenges of applying UK clinical guidelines to people with multimorbidity. Age Ageing. 2013;42:62–9. https://doi.org/10.1093/ageing/afs100 .
doi: 10.1093/ageing/afs100 pubmed: 22910303
Jamison J, Sutton S, Mant J, et al. Barriers and facilitators to adherence to secondary stroke prevention medications after stroke: analysis of survivors and caregivers views from an online stroke forum. BMJ Open. 2017;7:e016814. https://doi.org/10.1136/bmjopen-2017-016814 .
doi: 10.1136/bmjopen-2017-016814 pubmed: 28713074 pmcid: 5541606
Pindus DM, Mullis R, Lim L, et al. Stroke survivors’ and informal caregivers’ experiences of primary care and community healthcare services - a systematic review and meta-ethnography. PLoS ONE. 2018;13:e0192533. https://doi.org/10.1371/journal.pone.0192533 .
doi: 10.1371/journal.pone.0192533 pubmed: 29466383 pmcid: 5821463
Gynnild MN, Aakerøy R, Spigset O, et al. Vascular risk factor control and adherence to secondary preventive medication after ischaemic stroke. J Intern Med. 2021;289:355–68. https://doi.org/10.1111/joim.13161 .
doi: 10.1111/joim.13161 pubmed: 32743852
Kjörk EK, Gustavsson M, El-Manzalawy N, et al. Stroke-related health problems and associated actions identified with the post-stroke checklist among nursing home residents. BMC Cardiovasc Disord. 2022;22:50. https://doi.org/10.1186/s12872-022-02466-3 .
doi: 10.1186/s12872-022-02466-3 pubmed: 35164696 pmcid: 8842537

Auteurs

Kristina Månsson (K)

Department of Neurology, Skåne University Hospital, Jan Waldenströms gata 15, Malmö, 205 02, Sweden. kkmansson@gmail.com.
Department of Clinical Sciences Lund, Neurology, Lund University, Jan Waldenströms gata 15, Lund, 205 02, Sweden. kkmansson@gmail.com.

Martin Söderholm (M)

Department of Neurology, Skåne University Hospital, Jan Waldenströms gata 15, Malmö, 205 02, Sweden.
Department of Clinical Sciences Malmö, Epidemiology, Lund University, Jan Waldenströms gata 15, Lund, 205 02, Sweden.

Ida Berhin (I)

Department of Neurology, Skåne University Hospital, Jan Waldenströms gata 15, Malmö, 205 02, Sweden.
Department of Clinical Sciences Lund, Neurology, Lund University, Jan Waldenströms gata 15, Lund, 205 02, Sweden.

Hélène Pessah-Rasmussen (H)

Department of Neurology, Rehabilitation Medicine, Memory Clinic and Geriatrics, Skåne University Hospital, Malmö, Sweden.
Department of Clinical Sciences Lund, Rehabilitation Medicine, Lund University, Lund, Sweden.

Teresa Ullberg (T)

Department of Neurology, Skåne University Hospital, Jan Waldenströms gata 15, Malmö, 205 02, Sweden.
Department of Clinical Sciences Lund, Neurology, Lund University, Jan Waldenströms gata 15, Lund, 205 02, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH